The global minimally invasive surgery market was valued at $60,643.0 million in 2020, and is estimated to reach $94,421.7 million by 2030, growing a CAGR of 4.7% from 2021 to 2030.
Minimally invasive surgery (MIS) is a means of performing major surgeries with small incisions and cuts. MIS also refers to a variety of procedures and techniques that are used to decrease the amount of soft-tissue injury during surgery. Surgeons use special instrumentation and smaller incision sites to access joints or muscles for the required treatment. Nowadays open and conventional surgeries are done in rare complicated conditions only.
Growth of the global minimal invasive surgery market is majorly driven by alarming increase in prevalence of chronic diseases, such as gastrointestinal disease, urinalysis, kidney disorder, orthopedic disorder, and respiratory disease; rise in government initiatives for development of diagnostic and treatment instrument for conducting the procedure; surge in demand for minimally invasive surgery; and development of advanced healthcare infrastructure. According to the World Health Organization (WHO), in 2021, it was reported that around 343 million population were diagnosed with osteoarthritis, globally. Moreover, in 2018, the Ministry of Telangana, India announced free diagnostic services and launched central laboratory named as a Telangana Laboratory in the premises of the Institute of Preventive Medicine. Furthermore, in August 2020, Medicaroid, a medical robot company, announced the launch of first robotic surgery company. It became the first company in Japan to receive and sell robotic assisted minimal invasive surgery system. Thus, increase in number of key players for development of advanced technology is expected to propel the growth of the market.
Increase in the number of surgical procedures and surge in demand for laparoscopic surgery are the major factors that drive the global minimal invasive surgery market. Moreover, increase in incidences of kidney disorder significantly contributes toward the market growth. Rise in demand for effective treatment and less pain to patients acts as a key driving force for expansion of the global market. Furthermore, governments have taken multiple initiatives to develop a minimal invasive surgery service, which is expected to boost the market growth. Moreover, in June 2021, Medtronic, one of the global leader in medical technology company, announced the first patient procedure with the Hugo robotic assisted surgery system. This system offer minimal invasive surgery to enhance the quality of life of patient. Thus, advancements in technology for advanced robot assisted service in emerging nations is anticipated to provide lucrative opportunities for the market expansion. For instance, in October 2020, Sysmex Corporation, a healthcare company, announced the launch of hinotori surgical robot system, to perform minimal invasive laparoscopic surgery to decrease physical burden on patient and surgeon.
However, high cost associated with minimal invasive surgery procedure for treatment of chronic disease is anticipated to hinder the market growth. Rise in awareness regarding advantages of minimal invasive surgery, technological advancements in minimal invasive surgery, and increase in awareness among population for treatment of disease with less pain and more accuracy augment growth of the minimal invasive surgery sector. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the minimally invasive surgery market.
The global minimal invasive surgery market is segmented into service type, condition, end user, and region. By service type, the market is categorized into laparoscopic surgery, and robotic surgery. The laparoscopic surgery segment is further classified into appendectomy, hysterectomy, myomectomy, colectomy, and others. Further, the robotic surgery services segment is classified into colorectal surgery, gynecologic surgery, and others.
Depending on condition, it is categorized into gastrointestinal conditions, spinal conditions, gynecologic conditions, and other conditions. By end user, the market is fragmented into hospitals & clinics and ambulatory surgical centers.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Some of the major companies that operate in the global minimal invasive surgery market are Apollo Hospitals Enterprise Ltd, Bedfordshire Hospitals, Circle Health Ltd, Manipal Health Enterprises Pvt Ltd, King Fahd Medical City, Mount Elizabeth Hospital, Singapore General Hospital Ltd, Stanford Healthcare, The General Hospital Corporation, and The Johns Hopkins Hospital.
Minimally invasive surgery (MIS) is a means of performing major surgeries with small incisions and cuts. MIS also refers to a variety of procedures and techniques that are used to decrease the amount of soft-tissue injury during surgery. Surgeons use special instrumentation and smaller incision sites to access joints or muscles for the required treatment. Nowadays open and conventional surgeries are done in rare complicated conditions only.
Growth of the global minimal invasive surgery market is majorly driven by alarming increase in prevalence of chronic diseases, such as gastrointestinal disease, urinalysis, kidney disorder, orthopedic disorder, and respiratory disease; rise in government initiatives for development of diagnostic and treatment instrument for conducting the procedure; surge in demand for minimally invasive surgery; and development of advanced healthcare infrastructure. According to the World Health Organization (WHO), in 2021, it was reported that around 343 million population were diagnosed with osteoarthritis, globally. Moreover, in 2018, the Ministry of Telangana, India announced free diagnostic services and launched central laboratory named as a Telangana Laboratory in the premises of the Institute of Preventive Medicine. Furthermore, in August 2020, Medicaroid, a medical robot company, announced the launch of first robotic surgery company. It became the first company in Japan to receive and sell robotic assisted minimal invasive surgery system. Thus, increase in number of key players for development of advanced technology is expected to propel the growth of the market.
Increase in the number of surgical procedures and surge in demand for laparoscopic surgery are the major factors that drive the global minimal invasive surgery market. Moreover, increase in incidences of kidney disorder significantly contributes toward the market growth. Rise in demand for effective treatment and less pain to patients acts as a key driving force for expansion of the global market. Furthermore, governments have taken multiple initiatives to develop a minimal invasive surgery service, which is expected to boost the market growth. Moreover, in June 2021, Medtronic, one of the global leader in medical technology company, announced the first patient procedure with the Hugo robotic assisted surgery system. This system offer minimal invasive surgery to enhance the quality of life of patient. Thus, advancements in technology for advanced robot assisted service in emerging nations is anticipated to provide lucrative opportunities for the market expansion. For instance, in October 2020, Sysmex Corporation, a healthcare company, announced the launch of hinotori surgical robot system, to perform minimal invasive laparoscopic surgery to decrease physical burden on patient and surgeon.
However, high cost associated with minimal invasive surgery procedure for treatment of chronic disease is anticipated to hinder the market growth. Rise in awareness regarding advantages of minimal invasive surgery, technological advancements in minimal invasive surgery, and increase in awareness among population for treatment of disease with less pain and more accuracy augment growth of the minimal invasive surgery sector. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the minimally invasive surgery market.
The global minimal invasive surgery market is segmented into service type, condition, end user, and region. By service type, the market is categorized into laparoscopic surgery, and robotic surgery. The laparoscopic surgery segment is further classified into appendectomy, hysterectomy, myomectomy, colectomy, and others. Further, the robotic surgery services segment is classified into colorectal surgery, gynecologic surgery, and others.
Depending on condition, it is categorized into gastrointestinal conditions, spinal conditions, gynecologic conditions, and other conditions. By end user, the market is fragmented into hospitals & clinics and ambulatory surgical centers.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Some of the major companies that operate in the global minimal invasive surgery market are Apollo Hospitals Enterprise Ltd, Bedfordshire Hospitals, Circle Health Ltd, Manipal Health Enterprises Pvt Ltd, King Fahd Medical City, Mount Elizabeth Hospital, Singapore General Hospital Ltd, Stanford Healthcare, The General Hospital Corporation, and The Johns Hopkins Hospital.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the global minimal invasive surgery market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global minimal invasive surgery market.
KEY MARKET SEGMENTS
By Service Type
- Laparoscopic Surgery
- Appendectomy
- Hysterectomy
- Myomectomy
- Colectomy
- Others
- Robotic Surgery
- Colorectal Surgery
- Gynecologic Surgery
- Others
By Condition
- Gastrointestinal Conditions
- Spinal Conditions
- Gynecologic Conditions
- Other Conditions
By End User
- Hospitals and Clinics
- Ambulatory Surgical Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Apollo Hospitals Enterprise Ltd
- Bedfordshire Hospitals
- Circle Health Ltd
- Manipal Health Enterprises Pvt Ltd
- King Fahd Medical City
- Mount Elizabeth Hospital
- Singapore General Hospital Ltd
- Stanford Healthcare
- The General Hospital Corporation
- The Johns Hopkins Hospital
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: MINIMALLY INVASIVE SURGERY MARKET, BY SERVICE TYPE
CHAPTER 5: MINIMALLY INVASIVE SURGERY MARKET, BY CONDITION
CHAPTER 6: MINIMALLY INVASIVE SURGERY MARKET, BY END USER
CHAPTER 7: MINIMALLY INVASIVE SURGERY MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Apollo Hospitals Enterprise Ltd
- Bedfordshire Hospitals
- Circle Health Ltd
- Manipal Health Enterprises Pvt Ltd
- King Fahd Medical City
- Mount Elizabeth Hospital
- Singapore General Hospital Ltd S.A.ford Healthcare
- The General Hospital Corporation
- The Johns Hopkins Hospital
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
